Latest Updates

Xgeva is a monoclonal antibody that binds to RANKL, a protein essential for maintenance of healthy bone

Proposes doubling patent fee; 10 per cent surcharge on hard copy filing

Pays a lump-sum $550 mn

Acquires Dr Schleuniger Pharmatron for $15 million

MSF calls decision a "half-hearted compromise

Expands its worldwide efforts to promote educational opportunities through extended partnership with

Hughey earned his Ph.D. in pharmaceutics from The University of Texas at Austin

Will present report to the Department of Commerce by June 25

Bags recognition for its enterprise data integration

Focus on facilitation of development plans through advice procedures